In Vitro Activities of Trovafloxacin Against 557 Strains of Anaerobic Bacteria

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1996 Sep 1

PMID 8878617

Citations 20

Authors

H M Wexler

E Molitoris

D Molitoris

S M Finegold

Affiliations

Soon will be listed here.

Abstract

The antimicrobial activity of trovafloxacin for 557 strains of anaerobic bacteria was determined by the National Committee for Clinical Laboratory Standards-approved Wadsworth agar dilution technique. The species tested included Bacteroides fragilis (n = 91), other members of the B. fragilis group (n = 130), Campylobacter gracilis (n = 15), other Bacteroides spp. (n = 16), Prevotella spp. (n = 49), Porphyromonas spp. (n = 15), Fusobacterium spp. (n = 62), Bilophila wadsworthia (n = 24), Sutterella wadsworthensis (n = 21), Clostridium spp. (n = 61), Peptostreptococcus spp. (n = 38), and gram-positive non-spore-forming rods (n = 35). Trovafloxacin inhibited all strains of B. fragilis at < or = 0.5 microgram/ml, 99% of other B. fragilis group species at < or = 2 micrograms/ml, and 96% of all anaerobes tested at < or = 2 micrograms/ml.

Citing Articles

The new fluoroquinolones: A critical review.

Zhanel G, Walkty A, Vercaigne L, Karlowsky J, Embil J, Gin A Can J Infect Dis. 2012; 10(3):207-38.

PMID: 22346384 PMC: 3250697. DOI: 10.1155/1999/378394.

In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone.

Tanaka K, Mikamo H, Nakao K, Watanabe K Antimicrob Agents Chemother. 2006; 50(11):3908-13.

PMID: 17065629 PMC: 1635190. DOI: 10.1128/AAC.00639-06.

Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.

Peric M, Jacobs M, Appelbaum P Antimicrob Agents Chemother. 2004; 48(8):3188-92.

PMID: 15273148 PMC: 478502. DOI: 10.1128/AAC.48.8.3188-3192.2004.

In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.

Liebetrau A, Rodloff A, Behra-Miellet J, Dubreuil L Antimicrob Agents Chemother. 2003; 47(11):3667-71.

PMID: 14576144 PMC: 253765. DOI: 10.1128/AAC.47.11.3667-3671.2003.

Antibiotic resistance in bacteria isolated from subgingival plaque in a norwegian population with refractory marginal periodontitis.

Handal T, Caugant D, Olsen I Antimicrob Agents Chemother. 2003; 47(4):1443-6.

PMID: 12654689 PMC: 152519. DOI: 10.1128/AAC.47.4.1443-1446.2003.

References

Sutter V, Kwok Y, Bulkacz J . Comparative activity of ciprofloxacin against anaerobic bacteria. Antimicrob Agents Chemother. 1985; 27(3):427-8. PMC: 176292. DOI: 10.1128/AAC.27.3.427. View

Wexler H, Reeves D, Summanen P, Molitoris E, McTeague M, Duncan J . Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic Campylobacter gracilis-like clinical isolates. Int J Syst Bacteriol. 1996; 46(1):252-8. DOI: 10.1099/00207713-46-1-252. View

Watt B, Brown F . Is ciprofloxacin active against clinically important anaerobes?. J Antimicrob Chemother. 1986; 17(5):605-13. DOI: 10.1093/jac/17.5.605. View

Jones B, Geary I, Lee M, Duerden B . Activity of pefloxacin and thirteen other antimicrobial agents in vitro against isolates from hospital and genitourinary infections. J Antimicrob Chemother. 1986; 17(6):739-46. DOI: 10.1093/jac/17.6.739. View

King A, Phillips I . The comparative in-vitro activity of eight newer quinolones and nalidixic acid. J Antimicrob Chemother. 1986; 18 Suppl D:1-20. DOI: 10.1093/jac/18.supplement_d.1. View

Fernandes P, Shipkowitz N, BOWER R, Jarvis K, Weisz J, Chu D . In-vitro and in-vivo potency of five new fluoroquinolones against anaerobic bacteria. J Antimicrob Chemother. 1986; 18(6):693-701. DOI: 10.1093/jac/18.6.693. View

Fox A, Phillips I . The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom. J Antimicrob Chemother. 1987; 20(4):477-88. DOI: 10.1093/jac/20.4.477. View

Clarke A, Zemcov S . Comparative in vitro activity of lomefloxacin, a new difluoroquinolone. Eur J Clin Microbiol Infect Dis. 1989; 8(2):164-8. DOI: 10.1007/BF01963905. View

Venezia R, Yocum D, Robbiano E, Echols R . Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria. Antimicrob Agents Chemother. 1990; 34(9):1858-61. PMC: 171949. DOI: 10.1128/AAC.34.9.1858. View

10.

Wexler H, Molitoris E, Finegold S . In vitro activities of three of the newer quinolones against anaerobic bacteria. Antimicrob Agents Chemother. 1992; 36(1):239-43. PMC: 189287. DOI: 10.1128/AAC.36.1.239. View

11.

Goldstein E, Citron D . Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria. Antimicrob Agents Chemother. 1992; 36(5):1158-62. PMC: 188857. DOI: 10.1128/AAC.36.5.1158. View

12.

Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y . Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrob Agents Chemother. 1992; 36(7):1491-8. PMC: 191610. DOI: 10.1128/AAC.36.7.1491. View

13.

Bauernfeind A . Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990. J Antimicrob Chemother. 1993; 31(4):505-22. DOI: 10.1093/jac/31.4.505. View

14.

Barry A, Fuchs P, Citron D, Allen S, Wexler H . Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin. J Antimicrob Chemother. 1993; 31(6):893-900. DOI: 10.1093/jac/31.6.893. View

15.

Marshall S, Jones R . In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone. Antimicrob Agents Chemother. 1993; 37(12):2747-53. PMC: 192801. DOI: 10.1128/AAC.37.12.2747. View

16.

Spangler S, Jacobs M, Appelbaum P . Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob Agents Chemother. 1994; 38(10):2471-6. PMC: 284766. DOI: 10.1128/AAC.38.10.2471. View

17.

Wexler H, Molitoris E, Reeves D, Finegold S . In vitro activity of DU-6859a against anaerobic bacteria. Antimicrob Agents Chemother. 1994; 38(10):2504-9. PMC: 284775. DOI: 10.1128/AAC.38.10.2504. View

18.

Wexler H, Molitoris E, Reeves D, Finegold S . In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria. J Antimicrob Chemother. 1994; 34(4):579-84. DOI: 10.1093/jac/34.4.579. View

19.

Goldstein E, Citron D . Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals. Antimicrob Agents Chemother. 1985; 27(4):657-9. PMC: 180118. DOI: 10.1128/AAC.27.4.657. View